4/A: Viemed Healthcare President Michael Moore Amends SEC Filing After Stock Unit Vesting
SEC Form 4 Amendment
Viemed Healthcare's President, Michael Moore, amended a previous SEC filing to reflect the withholding of shares for tax obligations related to the vesting of restricted stock units.
Summary
- Michael Moore, President of Viemed Healthcare, amended a previous SEC Form 4 filing to accurately reflect changes in his beneficial ownership of company stock.
- The amendment addresses the vesting of 18,979 restricted stock units (RSUs) on January 18, 2025.
- As part of the vesting, 5,761 shares were withheld by the company to cover Mr. Moore's tax obligations.
- The price per share used for tax withholding was $8.15, based on the market closing price on January 17, 2025.
- Following these transactions, Mr. Moore directly owns 157,737 common shares and indirectly owns 1,722,614 shares through Moore Faster LLC.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to executive compensation. It does not contain any positive or negative news, but it is a necessary disclosure for transparency.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It reflects standard practices for handling the vesting of equity-based compensation.
Comparison to Industry Standards
- The vesting of restricted stock units and the subsequent withholding of shares for tax obligations are standard practices in executive compensation across publicly traded companies.
- Many companies use similar mechanisms to align executive interests with shareholder value and to manage tax liabilities associated with equity grants.
- The specific vesting schedule of three equal annual installments is also a common approach.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects a change in the beneficial ownership of company stock by a key executive.
- The tax withholding ensures compliance with tax regulations.
Key Dates
| Date | Description |
|---|---|
| 01/18/2022 | Restricted Stock Units (RSUs) granted to reporting person, which vest in three equal annual installments beginning on the first anniversary of the grant date. |
| 01/17/2025 | Date used to determine the market closing price of common shares for tax withholding purposes. |
| 01/18/2025 | Date of the restricted stock unit vesting and associated transactions. |
| 01/22/2025 | Original filing date of the Form 4 that was amended. |
| 01/23/2025 | Date of the amended filing. |
Keywords
Viemed Healthcare, Michael Moore, SEC Form 4, Restricted Stock Units, RSU, Beneficial Ownership, Stock Vesting, Tax Withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.